Loading…

Potent Cytotoxic C-11 Modified Geldanamycin Analogues

17-Allylamino-17-demethoxygeldanamycin (17-AAG) inhibits the activity of Hsp90, an important target for treatment of cancers. In an effort to identify analogues of geldanamycin (GDM) with properties superior to those of 17-AAG, we synthesized C-11 modified derivatives of GDM including ethers, esters...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 2009-05, Vol.52 (10), p.3265-3273
Main Authors: Tian, Zong-Qiang, Wang, Zhan, MacMillan, Karen S, Zhou, Yiqing, Carreras, Christopher W, Mueller, Thomas, Myles, David C, Liu, Yaoquan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a343t-82e947e7ce5df4dd005afeb8f00df8f45b7443e483860863c72426edd3c9d7183
cites cdi_FETCH-LOGICAL-a343t-82e947e7ce5df4dd005afeb8f00df8f45b7443e483860863c72426edd3c9d7183
container_end_page 3273
container_issue 10
container_start_page 3265
container_title Journal of medicinal chemistry
container_volume 52
creator Tian, Zong-Qiang
Wang, Zhan
MacMillan, Karen S
Zhou, Yiqing
Carreras, Christopher W
Mueller, Thomas
Myles, David C
Liu, Yaoquan
description 17-Allylamino-17-demethoxygeldanamycin (17-AAG) inhibits the activity of Hsp90, an important target for treatment of cancers. In an effort to identify analogues of geldanamycin (GDM) with properties superior to those of 17-AAG, we synthesized C-11 modified derivatives of GDM including ethers, esters, carbazates, ketones, and oximes and measured their affinity for Hsp90 and their ability to inhibit growth of human cancer cells. In accordance with crystal structures reported for complexes of GDMs with Hsp90, bulky groups attached to C-11 interfered with Hsp90 binding while smaller groups such as 11-O-methyl allowed Hsp90 binding. In addition, these analogues also showed in vitro cytotoxicity against human cancer cell lines. Esterfication of the 11-OH of 17-AAG eliminated Hsp90 binding in vitro. The readily hydrolyzed esters acted as prodrugs during the measurement of cytotoxicity. Thus, during these experiments, the esters were hydrolyzed, releasing 17-AAG. Several 11-O-methyl-17-alkylaminogeldanamycin analogues were identified with improved potency relative to 17-AAG.
doi_str_mv 10.1021/jm900098v
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67262869</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67262869</sourcerecordid><originalsourceid>FETCH-LOGICAL-a343t-82e947e7ce5df4dd005afeb8f00df8f45b7443e483860863c72426edd3c9d7183</originalsourceid><addsrcrecordid>eNpt0M1Kw0AUBeBBFFurC19AslFwEb3zl0yWJWgVKrrQdZjO3JGUJFMzidi3N9LQblzdzcc53EPIJYU7Cozer-sMADL1fUSmVDKIhQJxTKYAjMUsYXxCzkJYD4ZTxk_JhGYCpGRqSuSb77Dponzb-c7_lCbKY0qjF29LV6KNFlhZ3eh6a8ommje68p89hnNy4nQV8GK8M_Lx-PCeP8XL18VzPl_GmgvexYphJlJMDUrrhLUAUjtcKQdgnXJCrlIhOArFVQIq4SZlgiVoLTeZTaniM3Kzy920_mvo7Yq6DAarSjfo-1Ak6fCdSrIB3u6gaX0ILbpi05a1brcFheJvo2K_0WCvxtB-VaM9yHGUAVyPQAejK9fqxpRh7xiVNEk5HJw2oVj7vh3mCf8U_gLkSnih</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67262869</pqid></control><display><type>article</type><title>Potent Cytotoxic C-11 Modified Geldanamycin Analogues</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><creator>Tian, Zong-Qiang ; Wang, Zhan ; MacMillan, Karen S ; Zhou, Yiqing ; Carreras, Christopher W ; Mueller, Thomas ; Myles, David C ; Liu, Yaoquan</creator><creatorcontrib>Tian, Zong-Qiang ; Wang, Zhan ; MacMillan, Karen S ; Zhou, Yiqing ; Carreras, Christopher W ; Mueller, Thomas ; Myles, David C ; Liu, Yaoquan</creatorcontrib><description>17-Allylamino-17-demethoxygeldanamycin (17-AAG) inhibits the activity of Hsp90, an important target for treatment of cancers. In an effort to identify analogues of geldanamycin (GDM) with properties superior to those of 17-AAG, we synthesized C-11 modified derivatives of GDM including ethers, esters, carbazates, ketones, and oximes and measured their affinity for Hsp90 and their ability to inhibit growth of human cancer cells. In accordance with crystal structures reported for complexes of GDMs with Hsp90, bulky groups attached to C-11 interfered with Hsp90 binding while smaller groups such as 11-O-methyl allowed Hsp90 binding. In addition, these analogues also showed in vitro cytotoxicity against human cancer cell lines. Esterfication of the 11-OH of 17-AAG eliminated Hsp90 binding in vitro. The readily hydrolyzed esters acted as prodrugs during the measurement of cytotoxicity. Thus, during these experiments, the esters were hydrolyzed, releasing 17-AAG. Several 11-O-methyl-17-alkylaminogeldanamycin analogues were identified with improved potency relative to 17-AAG.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm900098v</identifier><identifier>PMID: 19405528</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Columbus, OH: American Chemical Society</publisher><subject>Antineoplastic agents ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - pharmacology ; Benzoquinones - chemistry ; Benzoquinones - pharmacology ; Biological and medical sciences ; Cell Line, Tumor ; Cell Proliferation - drug effects ; Esters ; General aspects ; HSP90 Heat-Shock Proteins - antagonists &amp; inhibitors ; HSP90 Heat-Shock Proteins - metabolism ; Humans ; Lactams, Macrocyclic - chemistry ; Lactams, Macrocyclic - pharmacology ; Medical sciences ; Pharmacology. Drug treatments ; Prodrugs - chemistry ; Protein Binding ; Structure-Activity Relationship</subject><ispartof>Journal of medicinal chemistry, 2009-05, Vol.52 (10), p.3265-3273</ispartof><rights>Copyright © 2009 American Chemical Society</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a343t-82e947e7ce5df4dd005afeb8f00df8f45b7443e483860863c72426edd3c9d7183</citedby><cites>FETCH-LOGICAL-a343t-82e947e7ce5df4dd005afeb8f00df8f45b7443e483860863c72426edd3c9d7183</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21516730$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19405528$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tian, Zong-Qiang</creatorcontrib><creatorcontrib>Wang, Zhan</creatorcontrib><creatorcontrib>MacMillan, Karen S</creatorcontrib><creatorcontrib>Zhou, Yiqing</creatorcontrib><creatorcontrib>Carreras, Christopher W</creatorcontrib><creatorcontrib>Mueller, Thomas</creatorcontrib><creatorcontrib>Myles, David C</creatorcontrib><creatorcontrib>Liu, Yaoquan</creatorcontrib><title>Potent Cytotoxic C-11 Modified Geldanamycin Analogues</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>17-Allylamino-17-demethoxygeldanamycin (17-AAG) inhibits the activity of Hsp90, an important target for treatment of cancers. In an effort to identify analogues of geldanamycin (GDM) with properties superior to those of 17-AAG, we synthesized C-11 modified derivatives of GDM including ethers, esters, carbazates, ketones, and oximes and measured their affinity for Hsp90 and their ability to inhibit growth of human cancer cells. In accordance with crystal structures reported for complexes of GDMs with Hsp90, bulky groups attached to C-11 interfered with Hsp90 binding while smaller groups such as 11-O-methyl allowed Hsp90 binding. In addition, these analogues also showed in vitro cytotoxicity against human cancer cell lines. Esterfication of the 11-OH of 17-AAG eliminated Hsp90 binding in vitro. The readily hydrolyzed esters acted as prodrugs during the measurement of cytotoxicity. Thus, during these experiments, the esters were hydrolyzed, releasing 17-AAG. Several 11-O-methyl-17-alkylaminogeldanamycin analogues were identified with improved potency relative to 17-AAG.</description><subject>Antineoplastic agents</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Benzoquinones - chemistry</subject><subject>Benzoquinones - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>Esters</subject><subject>General aspects</subject><subject>HSP90 Heat-Shock Proteins - antagonists &amp; inhibitors</subject><subject>HSP90 Heat-Shock Proteins - metabolism</subject><subject>Humans</subject><subject>Lactams, Macrocyclic - chemistry</subject><subject>Lactams, Macrocyclic - pharmacology</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Prodrugs - chemistry</subject><subject>Protein Binding</subject><subject>Structure-Activity Relationship</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNpt0M1Kw0AUBeBBFFurC19AslFwEb3zl0yWJWgVKrrQdZjO3JGUJFMzidi3N9LQblzdzcc53EPIJYU7Cozer-sMADL1fUSmVDKIhQJxTKYAjMUsYXxCzkJYD4ZTxk_JhGYCpGRqSuSb77Dponzb-c7_lCbKY0qjF29LV6KNFlhZ3eh6a8ommje68p89hnNy4nQV8GK8M_Lx-PCeP8XL18VzPl_GmgvexYphJlJMDUrrhLUAUjtcKQdgnXJCrlIhOArFVQIq4SZlgiVoLTeZTaniM3Kzy920_mvo7Yq6DAarSjfo-1Ak6fCdSrIB3u6gaX0ILbpi05a1brcFheJvo2K_0WCvxtB-VaM9yHGUAVyPQAejK9fqxpRh7xiVNEk5HJw2oVj7vh3mCf8U_gLkSnih</recordid><startdate>20090528</startdate><enddate>20090528</enddate><creator>Tian, Zong-Qiang</creator><creator>Wang, Zhan</creator><creator>MacMillan, Karen S</creator><creator>Zhou, Yiqing</creator><creator>Carreras, Christopher W</creator><creator>Mueller, Thomas</creator><creator>Myles, David C</creator><creator>Liu, Yaoquan</creator><general>American Chemical Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090528</creationdate><title>Potent Cytotoxic C-11 Modified Geldanamycin Analogues</title><author>Tian, Zong-Qiang ; Wang, Zhan ; MacMillan, Karen S ; Zhou, Yiqing ; Carreras, Christopher W ; Mueller, Thomas ; Myles, David C ; Liu, Yaoquan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a343t-82e947e7ce5df4dd005afeb8f00df8f45b7443e483860863c72426edd3c9d7183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Antineoplastic agents</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Benzoquinones - chemistry</topic><topic>Benzoquinones - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>Esters</topic><topic>General aspects</topic><topic>HSP90 Heat-Shock Proteins - antagonists &amp; inhibitors</topic><topic>HSP90 Heat-Shock Proteins - metabolism</topic><topic>Humans</topic><topic>Lactams, Macrocyclic - chemistry</topic><topic>Lactams, Macrocyclic - pharmacology</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Prodrugs - chemistry</topic><topic>Protein Binding</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tian, Zong-Qiang</creatorcontrib><creatorcontrib>Wang, Zhan</creatorcontrib><creatorcontrib>MacMillan, Karen S</creatorcontrib><creatorcontrib>Zhou, Yiqing</creatorcontrib><creatorcontrib>Carreras, Christopher W</creatorcontrib><creatorcontrib>Mueller, Thomas</creatorcontrib><creatorcontrib>Myles, David C</creatorcontrib><creatorcontrib>Liu, Yaoquan</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tian, Zong-Qiang</au><au>Wang, Zhan</au><au>MacMillan, Karen S</au><au>Zhou, Yiqing</au><au>Carreras, Christopher W</au><au>Mueller, Thomas</au><au>Myles, David C</au><au>Liu, Yaoquan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Potent Cytotoxic C-11 Modified Geldanamycin Analogues</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2009-05-28</date><risdate>2009</risdate><volume>52</volume><issue>10</issue><spage>3265</spage><epage>3273</epage><pages>3265-3273</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>17-Allylamino-17-demethoxygeldanamycin (17-AAG) inhibits the activity of Hsp90, an important target for treatment of cancers. In an effort to identify analogues of geldanamycin (GDM) with properties superior to those of 17-AAG, we synthesized C-11 modified derivatives of GDM including ethers, esters, carbazates, ketones, and oximes and measured their affinity for Hsp90 and their ability to inhibit growth of human cancer cells. In accordance with crystal structures reported for complexes of GDMs with Hsp90, bulky groups attached to C-11 interfered with Hsp90 binding while smaller groups such as 11-O-methyl allowed Hsp90 binding. In addition, these analogues also showed in vitro cytotoxicity against human cancer cell lines. Esterfication of the 11-OH of 17-AAG eliminated Hsp90 binding in vitro. The readily hydrolyzed esters acted as prodrugs during the measurement of cytotoxicity. Thus, during these experiments, the esters were hydrolyzed, releasing 17-AAG. Several 11-O-methyl-17-alkylaminogeldanamycin analogues were identified with improved potency relative to 17-AAG.</abstract><cop>Columbus, OH</cop><pub>American Chemical Society</pub><pmid>19405528</pmid><doi>10.1021/jm900098v</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2009-05, Vol.52 (10), p.3265-3273
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_67262869
source American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)
subjects Antineoplastic agents
Antineoplastic Agents - chemical synthesis
Antineoplastic Agents - pharmacology
Benzoquinones - chemistry
Benzoquinones - pharmacology
Biological and medical sciences
Cell Line, Tumor
Cell Proliferation - drug effects
Esters
General aspects
HSP90 Heat-Shock Proteins - antagonists & inhibitors
HSP90 Heat-Shock Proteins - metabolism
Humans
Lactams, Macrocyclic - chemistry
Lactams, Macrocyclic - pharmacology
Medical sciences
Pharmacology. Drug treatments
Prodrugs - chemistry
Protein Binding
Structure-Activity Relationship
title Potent Cytotoxic C-11 Modified Geldanamycin Analogues
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T10%3A05%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Potent%20Cytotoxic%20C-11%20Modified%20Geldanamycin%20Analogues&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Tian,%20Zong-Qiang&rft.date=2009-05-28&rft.volume=52&rft.issue=10&rft.spage=3265&rft.epage=3273&rft.pages=3265-3273&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm900098v&rft_dat=%3Cproquest_cross%3E67262869%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a343t-82e947e7ce5df4dd005afeb8f00df8f45b7443e483860863c72426edd3c9d7183%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67262869&rft_id=info:pmid/19405528&rfr_iscdi=true